Skip to main content
Download PDF

Preliminary evidence that lectins in infant soy formula apparently bind bovine milk exosomes and prevent their absorption in healthy adults

BMC Nutrition volume 8, Article number: 7 (2022) Cite this article

Abstract

Background

Milk exosomes and their microRNA (miR) cargos are bioavailable. The content of exosomes and miRs is negligible in infant formulas compared to human milk, and dietary depletion of exosomes led to changes in bacterial communities and impaired gut health in juvenile mice. Adverse effects of formula feeding may be compounded by using soy formulas due to exosome binding by abundant lectins in that matrix. The purpose of this study was to assess the bioavailability of milk exosomes and their miR cargos added to soy formula in adults, as well as the potential role of soy lectins in exosome bioavailability.

Methods

Eleven healthy adults (6 men, 5 women) enrolled in this randomized crossover study. Participants consumed 1.0 l of soy formula without (SF) or with (SFE) bovine milk exosomes added. Concentration-time curves of six plasma miRs were analyzed using reverse transcription quantitative PCR. Lectin affinity chromatography was used to assess the binding of exosomes by soy lectins. Data were analyzed by using paired t test. P < 0.05 was considered statistically significant.

Results

Consumption of SF and SFE did not elicit postprandial increases in plasma miRs. Approximately 39% of bovine milk exosome particles were retained by lectin columns.

Conclusions

We conclude that fortification of soy formulas with milk exosomes, in the absence of removing lectins, is not a viable strategy for delivering bioavailable exosomes and their miR cargos. Lectins in soy formulas bind glycoprotein on the surfaces of milk exosomes, thereby preventing exosome absorption.

Trial registration

ISRCTN registry ID: 16329971. Retrospectively registered on February 7th, 2019.

Peer Review reports

Introduction

Exosomes play essential role in cell-to-cell communication, which is facilitated by the binding of exosomes to receptors on the surface of recipient cells or internalization of exosomes and their cargos by recipient cells [1]. Among the regulatory cargos of exosomes, microRNAs (miRs) are of particular interest because more than 60% of human genes have conserved miR-binding sites, humans synthesize approximately 2000 miRs, and loss of miR maturation is embryonic lethal [2,3,4,5]. MiRs alter gene expression by binding to complementary sequences in the 3′-untranslated regions in mRNA, leading to mRNA degradation or blockage of translation [6, 7].

Exosomes are present in virtually all fluids, including human and bovine milk [8,9,10,11]. Encapsulation of miRs in exosomes confers protection against degradation by low pH and enzymes in the gastrointestinal tract [9] and a pathway for internalization by receptor cells [12]. We were the first to report that exosomes and their miR cargos may not solely originate in endogenous synthesis but may also be absorbed from milk [13,14,15]. Our discoveries were confirmed by independent laboratories while a few laboratories raised the concern that the amount of miRs absorbed from milk may be insufficient to elicit biological effects (reviewed in [16]).

Dietary depletion of milk exosomes and their RNA cargos elicited phenotypes such as increase in purine metabolites in human and murine body fluids and tissues [17]. Dietary depletion of bovine milk exosomes (BMEs) caused a variety of phenotypes in mice including a moderate loss of grip strength, an increase in the severity of symptoms of inflammatory bowel disease, a decrease in postnatal survival and changes in bacterial communities in the ceca [17,18,19,20,21], whereas BMEs enhanced goblet cell activity and prevented the development of necrotizing enterocolitis in mice [22]. These observations raise concerns regarding infant nutrition by using formulas, because previous reports agree that the content of exosomes and miR cargos is modest to not detectable in milk formulas [9, 11, 23]. The nutritional importance of these observations has been highlighted in a recent review [24]. Effects may be compounded in infants fed soy formulas, which lack milk altogether. The global soy infant formula market is predicted to grow $278 million during 2019 to 2023 [25]. One might want to explore the possibility to fortify soy formulas with milk exosomes to make them more similar to human milk. There is precedent for optimizing nutrient content of infant formulas through fortification by formula manufacturers [26, 27]. The mere fortification of soy formulas with milk exosomes could prove problematic because lectins, including those in soy, bind to carbohydrates and aggregate cells and exosomes [28, 29]. In soybeans, 0.5% of proteins are lectins [30]. Proteins on the outer exosome surface are extensively glycosylated [31], making the targets for precipitation by lectins. Lectins in legumes such as soy are resistant to heat denaturation, and heating of legumes at 70 °C for several hours has little or no effect on lectin activity [32]. Infant formula is pasteurized by holding a temperature of up to 94 °C for up to 30 s [33].

This study assessed the bioavailability of exosomal miRs in soy infant formulas fortified with BMEs. Because of the need to perform serial blood collections, this study was conducted in healthy adults as a model for infants. We focused on immune-related miRs (miR-15b, miR-21-5p, miR-34a-5p, miR-106b, miR-155, and miR-223), because they are abundant in human milk and their nucleotide sequences are identical in humans and cows [3, 34].

Methods

Participants

Eleven healthy adults (6 men, 5 women) participated in this study. Subjects were 28.8 ± 3.51 years old and had a BMI of 23.6 ± 2.24 kg/m2 (means ± SD). Exclusion criteria included pregnancy, smoking, milk allergies, and self-reported health problems. The Institutional Review Board at the University of Nebraska-Lincoln approved this protocol, and all participants provided a signed informed consent form before participation (protocol number IRB# 20131013755FB). This study was retrospectively registered as a clinical trial with the ISCRTN registry (ISRCTN16329971) on 07/02/2019.

Experimental design of the formula feeding study

We used a randomized cross-over design. Participants were randomly assigned to treatment groups (Enfamil; milk-free and lactose-free powder with iron) without (SF) or with (SFE) BME fortification and a washout period of at least 1 week between treatments by using computerized numbers. Bovine milk contains approximately 1014 exosomes per milliliter [35]. Exosomes were isolated from 1.0 l bovine milk (1% fat) obtained from a local grocery store. Exosomes were isolated by ultracentrifugation as described previously [14, 36] and re-suspended in a final volume of 1 ml in sterile phosphate-buffered saline and stored at − 80 °C until use. In previous studies we reported the results from BME authentication by transmission electron microscopy, Nanosight size analysis and immunoblotting of exosome markers and markers of extracellular vesicles other than exosomes [14, 15, 35]. Soy infant formula (Enfamil; milk-free and lactose-free powder with iron) was purchased from a local grocery store. A 1.0-l dose of soy infant formula was prepared following the manufacturer’s instructions. For fortification of soy formula drinks, a homogenous suspension of 1 ml of exosomes obtained from 1.0 l of bovine milk was added to the soy infant formula drink, and thoroughly mixed before human consumption. We assessed the miR content in BMEs by RNA-sequencing analysis and reported the findings in a previous publication [35] A 28-yr-old male participant (77 kg body weight, 1.72 m height) served as reference and consumed 1.0 l formula. The volume consumed by the other subjects was adjusted by total body water [37]. The volume consumed equaled 0.84 ± 0.15 l (mean ± SD) for the 11 participants. This dose produced a robust increase in plasma miR concentrations in a previous study in a similar cohort of adults [13]. Participants consumed SF or SFE in a randomized order.

Sample collection and miR analysis

Blood samples were collected before (baseline; time = 0 h) and 3, 6, and 9 h after formula consumption. Blood samples were collected in EDTA tubes to avoid loss of exosomes by binding to heparin [38]. Plasma was separated from cellular materials by using Histopaque gradient centrifugation and stored at − 80 °C until miR analysis [39]. Samples compromised by hemolysis were discarded, because the release of miRs from red blood cells is a confounder in miR analysis [40]. The nucleotide sequences of the vast majority of mature bovine miRs are identical to their human orthologs, including miR-1, miR-15b, miR-21-5p, miR-34a-5p, miR-106b, miR-155 and miR-223 [3]. MiR-1 was tested because it is not detectable in bovine milk exosomes (negative control). The other six miRs were tested because they were the focus of a parallel study of the amelioration inflammatory bowel disease by miRs in milk exosomes [19]. Note that some of these miRs are less abundant than miR-30d, miR-148a and the let-7 family of miRs in human and bovine milk exosomes [9, 11, 24]. A synthetic miR, miSPIKE (IDT DNA, Inc.) was added to plasma samples after denaturation with lysis buffer and served as external standard. Plasma miRs were measured by using reverse transcription quantitative PCR (RT-qPCR) as previously described, modified by purification of columns in NucleoSpin miRNA plasma kit (Macherey-Nagel) described below [13]. The kit provides a proprietary universal reverse primer, whereas forward primers are miR specific (Table 1). Under the experimental conditions, miRs that produced Ct values ≤30.0 were considered detectable. Concerns were raised regarding the contamination of spin columns for RNA isolation with microbial RNAs, which might cause artifacts in miR analysis [41]. We formally tested for column contamination by passing molecular biology grade water through hypochlorite-treated and non-treated columns and compared the Ct values of the six miRs in the two treatments by RT-qPCR. Although, we could not reproduce the finding that spin columns are contaminated (see Results), we decided to err on the side of caution and treated columns with 0.5% sodium hypochlorite [41].

Table 1 PCR primers used for the quantification of miRs in human plasma
Full size table

Lectin affinity chromatography

Plastic syringes (3-ml volume; BD Biosciences cat. no. 309657) were fitted with Grade 6 qualitative filter paper (Whatman cat. no. 1006–125) in the bottom and packed with 2 ml agarose-bound soybean agglutinin (Vector Laboratories, cat. no. AL-1013) and equilibrated with binding buffer (10 mM HEPES, 150 mM NaCl, pH 7.5) at room temperature. A 1-ml suspension of BMEs with particle and protein concentrations (1013 BMEs; 19.8 mg/ml protein) was loaded and 1 ml flow through (referred to as FB in Results) was collected. One 1 ml binding buffer was added, the stopcock was closed, and columns were incubated at room temperature for 60 min. Columns were washed with binding buffer and 1-ml fractions were collected until the absorbance at 280 nm in the eluate returned to baseline values (referred to as F1- F16 in Results). Next, elution buffer (10 mM HEPES, 150 mM NaCl, 200 mM N-acetylgalactosamine, pH 7.5) was applied and 100-μl fractions were collected (referred to as E1- E30 in Results). The absorbance at 280 nm in fraction E30 was the same as in elution buffer (blank). The number of BMEs in F1 – E30 was assessed by using a Malvern NanoSight NS300 nanoparticle tracking instrument.

Statistical analyses

Normality of data distribution was determined by using the Kolmogorov-Smirnov test. Data were analyzed by using paired t test. Data were calculated by using GraphPad Prism 6 (GraphPad Software). Data are reported as means ± SD. Differences were considered statistically significant if P < 0.05.

Results

Bioavailability of miRs in SF and SFE

Four of the six miRs tested were detectable in human plasma, miR-15b, miR-21-5p, miR-106b and miR-223. MiR-34a-5p and miR-155 were not detectable before and after consumption of SF and SFE (Ct values ≈34). Both SF and SFE failed to elicit a significant postprandial increase in plasma miR concentrations for any of the miRs tested (Table 2). MiR-1 was used as a negative control because it is not detectable in bovine milk [13]. The Ct values for miSpike were not significantly different among time points but were well within detection limits (Ct values 22 ± 1.1 to 23 ± 1.9), whereas Ct values were 31 ± 1.3 to 33 ± 1.9 for miR-1. We could not reproduce a previous report that suggested contamination of spin columns with small bacterial RNAs. Briefly, when we passed molecular biology grade water through hypochlorite-treated and non-treated columns and compared the Ct values of the six miRs in the two treatments by RT-qPCR (N = 5 per treatment), Ct values were greater than 35 in all samples tested.

Table 2 Ct values of plasma miRs before and after consumption of SF and SFE in healthy adults1
Full size table

The failure of BMEs fortification to elicit a postprandial increase in plasma miR concentrations is consistent with agglutination of BMEs by the soy lectins in formulas. We formally tested for this possibility by using soy lectin affinity chromatography. Approximately 39% from a suspension of BMEs in 1.4 × 1013 particles/buffer were retained by agarose-bound soybean agglutinin (Fig. 1), suggesting that the addition of BMEs to soy formulas is not a viable fortification strategy.

Fig. 1
figure 1

Retention of bovine milk exosomes by lectin affinity chromatography. Fractions F1 – F16 were collected after loading and elution with 1 ml binding buffer; fractions E1 – E30 were collected after elution with 1 ml elution buffer

Full size image

Discussion

This study represents an important advance in the field of milk exosomes and their miR cargos, particularly as it relates to infant nutrition. SF does not contain milk exosomes and the mere addition of BMEs in SFE does not lead to a detectable increase in the plasma concentrations of the six miRs tested here. Our studies provide evidence that absorption of BMEs added to SF is prevented by BMEs agglutination by soy lectins. While the importance of dietary miRs for the optimal development of infants remains to be demonstrated, evidence suggests that milk exosomes may have positive effects on the health of infants. It remains to be determined whether removal of lectins from SFs can be achieved on a large scale at reasonable cost, and whether such treatment is desirable from a dietary point of view. Note that, in addition to the studies of SFs reported here, milk formulas also contain amounts of exosomes and miRs far below those in human milk [9, 11, 23].

Most Americans do not meet the recommendation by the American Academy of Pediatrics to exclusively breast feed infants in the first 6 months of life [42]. Only 26% of the children born in 2017 were exclusively breastfed through 6 months in the U.S. [43]. When framed in the context of the number of births in the U.S., approximately 2.78 million out of the 3.75 million infants born in the U.S. in 2019 were exclusively or partially fed with formulas during the first 6 months of life, i.e., the magnitude of translational activities must not be underestimated [44]. It has been reported that infants fed with soy formulas displayed transient delays in cognitive performance compared to breastfed infants, and formula-fed infants have a greater risk for becoming obese and develop diabetes and cardiovascular disease later in life [45,46,47,48,49,50,51].

Our findings point toward additional studies needed in the field of milk exosomes and infant nutrition. One could consider identifying the glycan features on the exosome surface responsible for the interaction between bovine exosomes and human cells. For example, future studies need to assess whether depletion of lectins in soy formulas results in the absorption of BMEs and their miR cargos added to formulas and explore the removal of lectins under controlled conditions. Ongoing studies in our laboratory address this question, as well as non-canonical pathways of exosome signaling such as changes in the gut microbiome, the binding of RNAs to Toll-like receptors, and biological activities of RNAs other than miRs. Finally, we intend to assess the developmental advantage, if any, conferred by milk exosomes to nursing offspring in mammals.

Conclusions

We conclude that fortification of SF with BMEs is not a viable strategy when the goal is to provide bioavailable exosomes and miR cargos to infants. Any such strategies would need to be accompanied by prior removal of lectins from soy formulas.

Availability of data and materials

All data generated during this study are included in this published article.

Abbreviations

BMEs:

Bovine milk exosomes

Ct:

Cycle threshold

miR:

microRNA

RT-qPCR:

Reverse-transcription quantitative PCR

SF:

Soy formula

SFE:

Soy formula fortified with bovine milk exosomes

References

  1. OBrien K, Breyne K, Ughetto S, Laurent LC, Breakefield XO. RNA delivery by extracellular vesicles in mammalian cells and its applications. Nat Rev Mol Cell Biol. 2020;21(10):585–606.

    Google Scholar 

  2. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19(1):92–105.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Kozomara A, Birgaoanu M, Griffiths-Jones S. miRBase: from microRNA sequences to function. Nucleic Acids Res. 2019;47(D1):D155–D62.

    CAS  PubMed  Google Scholar 

  4. Wu Q, Song R, Ortogero N, Zheng H, Evanoff R, Small CL, et al. The RNase III enzyme DROSHA is essential for microRNA production and spermatogenesis. J Biol Chem. 2012;287(30):25173–90.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, Li MZ, et al. Dicer is essential for mouse development. Nat Genet. 2003;35(3):215–7.

    CAS  PubMed  Google Scholar 

  6. Schirle NT, Sheu-Gruttadauria J, MacRae IJ. Structural basis for microRNA targeting. Science. 2014;346(6209):608–13.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Ricci EP, Limousin T, Soto-Rifo R, Rubilar PS, Decimo D, Ohlmann T. miRNA repression of translation in vitro takes place during 43S ribosomal scanning. Nucleic Acids Res. 2013;41(1):586–98.

    CAS  PubMed  Google Scholar 

  8. Lasser C, Alikhani VS, Ekstrom K, Eldh M, Paredes PT, Bossios A, et al. Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages. J Transl Med. 2011;9:9.

    PubMed  PubMed Central  Google Scholar 

  9. Izumi H, Kosaka N, Shimizu T, Sekine K, Ochiya T, Takase M. Bovine milk contains microRNA and messenger RNA that are stable under degradative conditions. J Dairy Sci. 2012;95(9):4831–41.

    CAS  PubMed  Google Scholar 

  10. Sun J, Aswath K, Schroeder SG, Lippolis JD, Reinhardt TA, Sonstegard TS. MicroRNA expression profiles of bovine milk exosomes in response to Staphylococcus aureus infection. BMC Genomics. 2015;16(1):806.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Leiferman A, Shu J, Upadhyaya B, Cui J, Zempleni J. Storage of extracellular vesicles in human milk, and microRNA profiles in human milk exosomes and infant formulas. J Pediatr Gastroenterol Nutr. 2019;69(2):235–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Escrevente C, Keller S, Altevogt P, Costa J. Interaction and uptake of exosomes by ovarian cancer cells. BMC Cancer. 2011;11:108.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Baier SR, Nguyen C, Xie F, Wood JR, Zempleni J. MicroRNAs are absorbed in biologically meaningful amounts from nutritionally relevant doses of cow’s milk and affect gene expression in peripheral blood mononuclear cells, HEK-293 kidney cell cultures, and mouse livers. J Nutr. 2014;144:1495–500.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Wolf T, Baier SR, Zempleni J. The intestinal transport of bovine milk exosomes is mediated by endocytosis in human colon carcinoma caco-2 cells and rat small intestinal IEC-6 cells. J Nutr. 2015;145:2201–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Manca S, Upadhyaya B, Mutai E, Desaulniers AT, Cederberg RA, White BR, et al. Milk exosomes are bioavailable and distinct microRNA cargos have unique tissue distribution patterns. Sci Rep. 2018;8(1):11321.

    PubMed  PubMed Central  Google Scholar 

  16. Zempleni J, Sukreet S, Zhou F, Wu D, Mutai E. Milk-derived exosomes and metabolic regulation. Annu Rev Anim Biosci. 2019;15(7):245–62.

    Google Scholar 

  17. Aguilar-Lozano A, Baier SR, Grove R, Shu J, Giraud D, Mercer KE, et al. Concentrations of purine metabolites are elevated in fluids from adults and infants and in livers from mice fed diets depleted of bovine milk exosomes and their RNA cargos. J Nutr. 2018;148:1886–94.

    PubMed  PubMed Central  Google Scholar 

  18. Leiferman A, Shu J, Grove R, Cui J, Adamec J, Zempleni J. A diet defined by its content of bovine milk exosomes and their RNA cargos has moderate effects on gene expression, amino acid profiles and grip strength in skeletal muscle in C57BL/6 mice. J Nutr Biochem. 2018;59:123–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Wu D, Kittana H, Shu J, Kachman SD, Cui J, Ramer-Tait AE, et al. Dietary depletion of milk exosomes and their microRNA cargos elicits a depletion of miR-200a-3p and elevated intestinal inflammation and CXCL9 expression in Mdr1a−/− mice. Curr Dev Nutr. 2019;3:122.

    Google Scholar 

  20. Zhou F, Paz HA, Sadri M, Cui J, Kachman SD, Fernando SC, et al. Dietary bovine bilk exosomes elicit changes in bacterial communities in C57BL/6 mice. Am J Physiol Gastrointest Liver Physiol. 2019;317(11):G618–G24.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Sadri M, Shu J, Kachman SD, Cui J, Zempleni J. Milk exosomes and microRNAs cross the placenta and promote embryo survival in mice. Reproduction. 2020;160:501–9.

    CAS  PubMed  Google Scholar 

  22. Li B, Hock A, Wu RY, Minich A, Botts SR, Lee C, et al. Bovine milk-derived exosomes enhance goblet cell activity and prevent the development of experimental necrotizing enterocolitis. PLoS One. 2019;14(1):e0211431.

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Alsaweed M, Lai CT, Hartmann PE, Geddes DT, Kakulas F. Human milk miRNAs primarily originate from the mammary gland resulting in unique miRNA profiles of fractionated milk. Sci Rep. 2016;6:20680.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Melnik BC, Stremmel W, Weiskirchen R, John SM, Schmitz G. Exosome-derived microRNAs of human milk and their effects on infant health and development. Biomolecules. 2021;11(6):851

  25. Technavio R. Soy-based infant formula market to grow by USD 277.69 million, at 3% CAGR during 2019-2023 Toronto, ON (Canada): Technavio; 2019 [Available from: https://www.businesswire.com/news/home/20190626005474/en/.

    Google Scholar 

  26. Kent G. Regulating fatty acids in infant formula: critical assessment of U.S. policies and practices. Int Breastfeed J. 2014;9(1):2.

    PubMed  PubMed Central  Google Scholar 

  27. Vandenplas Y, Zakharova I, Dmitrieva Y. Oligosaccharides in infant formula: more evidence to validate the role of prebiotics. Brit J Nutr. 2015;113(9):1339–44.

    CAS  PubMed  Google Scholar 

  28. Sharon N, Lis H. Lectins: cell-agglutinating and sugar-specific proteins. Science. 1972;177(4053):949–59.

    CAS  PubMed  Google Scholar 

  29. Shtam TA, Burdakov VS, Landa SB, Naryzhny SN, Bairamukov VY, Malek AV, et al. Aggregation by lectin-methodical approach for effective isolation of exosomes from cell culture supernatant for proteome profiling. Tsitologiia. 2017;59(1):5–12.

    CAS  PubMed  Google Scholar 

  30. Brandon DL, Friedman M. Immunoassays of soy proteins. J Agric Food Chem. 2002;50(22):6635–42.

    CAS  PubMed  Google Scholar 

  31. Williams C, Royo F, Aizpurua-Olaizola O, Pazos R, Boons GJ, Reichardt NC, et al. Glycosylation of extracellular vesicles: current knowledge, tools and clinical perspectives. J Extracell Vesicles. 2018;7(1):1442985.

    PubMed  PubMed Central  Google Scholar 

  32. Pusztai A, Grant G. Assessment of lectin inactivation by heat and digestion. Methods Mol Med. 1998;9:505–14.

    CAS  PubMed  Google Scholar 

  33. Sun X, Wang C, Wang H, Guo M. Effects of processing on structure and thermal properties of powdered preterm infant formula. J Food Sci. 2018;83(6):1685–94.

    CAS  PubMed  Google Scholar 

  34. Zhou Q, Li M, Wang X, Li Q, Wang T, Zhu Q, et al. Immune-related microRNAs are abundant in breast milk exosomes. Int J Biol Sci. 2012;8(1):118–23.

    CAS  PubMed  Google Scholar 

  35. Sukreet S, Pereira Braga C, An TT, Adamec J, Cui J, Trible B, et al. Isolation of extracellular vesicles from byproducts of cheese making by tangential flow filtration yields heterogeneous fractions of nanoparticles. J Dairy Sci. 2021;104:9478–93.

    CAS  PubMed  Google Scholar 

  36. Izumi H, Tsuda M, Sato Y, Kosaka N, Ochiya T, Iwamoto H, et al. Bovine milk exosomes contain microRNA and mRNA and are taken up by human macrophages. J Dairy Sci. 2015;98(5):2920–33.

    CAS  PubMed  Google Scholar 

  37. Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr. 1980;33(1):27–39.

    CAS  PubMed  Google Scholar 

  38. Balaj L, Atai NA, Chen W, Mu D, Tannous BA, Breakefield XO, et al. Heparin affinity purification of extracellular vesicles. Sci Rep. 2015;5:10266.

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Zempleni J, Mock DM. Mitogen-induced proliferation increases biotin uptake into human peripheral blood mononuclear cells. Am J Phys Cell Phys. 1999;276(5):C1079–84.

    CAS  Google Scholar 

  40. Wang L, Sadri M, Giraud D, Zempleni J. RNase H2-dependent polymerase chain reaction and elimination of confounders in sample collection, storage, and analysis strengthen evidence that microRNAs in bovine milk are bioavailable in humans. J Nutr. 2018;148(1):153–9.

    PubMed  PubMed Central  Google Scholar 

  41. Heintz-Buschart A, Yusuf D, Kaysen A, Etheridge A, Fritz JV, May P, et al. Isolation of nucleic acids from low biomass samples: detection and removal of sRNA contaminants. BMC Biol. 2018;16:52.

    PubMed  PubMed Central  Google Scholar 

  42. American Academy of Pediatrics, section on breastfeeding. Breastfeeding and the use of human milk. Pediatrics. 2012;129(3):e827–e41.

  43. Centers for Disease Control and Prevention. Breastfeeding among U.S. children born 2010–2017, CDC national immunization surveys [Internet]. 2019 [cited 12/09/2020]. Available from: http://www.cdc.gov/breastfeeding/data/nis_data/index.htm.

  44. Centers for Disease Control and Prevention. Births and Natality Atlanta, GA2017 [Available from: https://www.cdc.gov/nchs/fastats/births.htm.

  45. Andres A, Cleves MA, Bellando JB, Pivik RT, Casey PH, Badger TM. Developmental status of 1-year-old infants fed breast milk, cow's milk formula, or soy formula. Pediatrics. 2012;129(6):1134–40.

    PubMed  Google Scholar 

  46. Ong KK, Loos RJ. Rapid infancy weight gain and subsequent obesity: systematic reviews and hopeful suggestions. Acta Paediatr. 2006;95(8):904–8.

    PubMed  Google Scholar 

  47. Huang J, Zhang Z, Wu Y, Wang Y, Wang J, Zhou L, et al. Early feeding of larger volumes of formula milk is associated with greater body weight or overweight in later infancy. Nutr J. 2018;17(1):12.

    PubMed  PubMed Central  Google Scholar 

  48. Karaolis-Danckert N, Gunther AL, Kroke A, Hornberg C, Buyken AE. How early dietary factors modify the effect of rapid weight gain in infancy on subsequent body-composition development in term children whose birth weight was appropriate for gestational age. Am J Clin Nutr. 2007;86(6):1700–8.

    CAS  PubMed  Google Scholar 

  49. Chomtho S, Wells JC, Williams JE, Davies PS, Lucas A, Fewtrell MS. Infant growth and later body composition: evidence from the 4-component model. Am J Clin Nutr. 2008;87(6):1776–84.

    CAS  PubMed  Google Scholar 

  50. Owen CG, Martin RM, Whincup PH, Smith GD, Cook DG. Does breastfeeding influence risk of type 2 diabetes in later life? A quantitative analysis of published evidence. Am J Clin Nutr. 2006;84(5):1043–54.

    CAS  PubMed  Google Scholar 

  51. Singhal A. Early nutrition and long-term cardiovascular health. Nutr Rev. 2006;64(5 Pt 2):S44–9 discussion S72–91.

    PubMed  Google Scholar 

Download references

Acknowledgements

The authors acknowledge the use of the Biomedical and Obesity Research Core in the Nebraska Center for the Prevention of Obesity Disease through Dietary Molecules (NIH 1P20GM104320) at the University of Nebraska- Lincoln.

Funding

Financial support provided by the NIH (grant 1P20GM104320), NIFA (grants 2015–67017-23181 and 2016–67001-25301), the Gerber Foundation, the Food for Health Initiative in the Office of the President of the University of Nebraska, the University of Nebraska Agricultural Research Division (Hatch Act), and USDA multistate group W4002 (all to J.Z.).

Author information

Affiliations

  1. Present address: Department of Nutrition and Health Sciences, University of Nebraska-Lincoln, 316C Leverton Hall, Lincoln, NE, 68583, USA

    Ezra Mutai, Alice Kah Hui Ngu & Janos Zempleni

Authors
  1. Ezra Mutai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alice Kah Hui Ngu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Janos Zempleni
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

J.Z. conceived the project; E.M., A.N., and J.Z. designed the research; E.M., and A. N conducted research and analyzed the data; E.M. and J.Z. wrote the manuscript; and J.Z. had primary responsibility for the final content. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Janos Zempleni.

Ethics declarations

Ethics approval and consent to participate

The Institutional Review Board (IRB) at the University of Nebraska- Lincoln approved the protocol used in this study (IRB Approval #: 20131013755FB), and all subjects signed an informed consent form before participation. All methods were carried out in accordance with relevant guidelines and regulations.

Consent for publication

Not applicable.

Competing interests

J.Z. serves as consultant for PureTech Health, Inc. The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mutai, E., Ngu, A.K.H. & Zempleni, J. Preliminary evidence that lectins in infant soy formula apparently bind bovine milk exosomes and prevent their absorption in healthy adults. BMC Nutr 8, 7 (2022). https://doi.org/10.1186/s40795-022-00503-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40795-022-00503-0

Keywords

  • Bioavailability
  • Bovine milk exosomes
  • Human
  • Infant soy formula
  • Lectins
  • microRNA
  • Milk

BMC Nutrition

ISSN: 2055-0928

Contact us